As a circulating biomarker, PTHrP (12–48) is significantly associated with breast cancer bone metastasis and locally regulates the differentiation of hematopoietic cells and the activity of osteoclasts in the tumor–bone marrow microenvironment, to promote tumor bone metastasis [109]. Here, PTHLH is linked to breast cancer.